Profil
Bernd Kullmann is currently the SVP-Head Operations & Project Management at Sigilon Therapeutics, Inc. Prior to this, he worked as the Head-Supply Chain at MediVation, Inc. and later at BeiGene Ltd. as the Head-Supply Chain from 2019 to 2022.
Mr. Kullmann holds an MBA from Carnegie Mellon University and an undergraduate degree from Norwich University.
Aktiva positioner av Bernd Kullmann
| Företag | Position | Start |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Verksamhetschef | - |
Tidigare kända positioner av Bernd Kullmann
| Företag | Position | Slut |
|---|---|---|
| BEIGENE LTD | Företagsledare/Principal | 2022-04-01 |
MediVation, Inc. /MA/
MediVation, Inc. /MA/ Internet Software/ServicesTechnology Services Provides fully automated Web-based communications systems to educate and communicate with patients securely on-line | Företagsledare/Principal | - |
Bernd Kullmanns utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediVation, Inc. /MA/
MediVation, Inc. /MA/ Internet Software/ServicesTechnology Services Provides fully automated Web-based communications systems to educate and communicate with patients securely on-line | Technology Services |
Norwich University
Norwich University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Sigilon Therapeutics, Inc.
Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
















